KP Tissue (TSE:KPT – Get Free Report) had its price objective decreased by stock analysts at Desjardins from C$10.00 to C$8.50 in a research note issued on Thursday,BayStreet.CA reports. The brokerage presently has a “hold” rating on the stock. Desjardins’ target price suggests a potential upside of 5.72% from the stock’s current price.
Separately, CIBC reduced their target price on shares of KP Tissue from C$9.00 to C$8.50 in a research report on Wednesday, January 15th.
Check Out Our Latest Analysis on KPT
KP Tissue Price Performance
Insider Buying and Selling
In other KP Tissue news, Director Mario Gosselin sold 18,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of C$8.19, for a total transaction of C$147,420.00. Corporate insiders own 0.14% of the company’s stock.
About KP Tissue
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Featured Articles
- Five stocks we like better than KP Tissue
- Compound Interest and Why It Matters When Investing
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Short Selling – The Pros and Cons
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
- The Role Economic Reports Play in a Successful Investment Strategy
- Taiwan Semi’s $100 Billion Investment: Fate of the Chipmakers
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.